A study suggests that “chief” cells in the stomach act as reserve stem cells that are activated by tissue damage and may be the long-sought source of gastric cancer. “This is the first definitive ...

Addition of AgenT-797 with Checkpoint Inhibitors, BOT/BAL, and Chemotherapy Demonstrates Robust Immune Activation, Offering ...

Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate ...

Stomach cancer is when abnormal cells in the stomach start to grow and divide in an uncontrolled way. It is also called gastric cancer. The stomach is part of the digestive system. It's in the upper ...

Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate stomach problems. PPIs are activated in the acid-producing cells of the ...

Her favorite projects involve sharing the insights of science and medicine. View Full Profile. Learn about our Editorial Policies. “Our ability to identify and purify tumour-resident stem cells in ...

A novel 3D bioprinted gastric cancer model using patient-derived tissues predicts drug responses, enhancing personalized ...

Prognostic impact of postoperative complications after neoadjuvant therapy followed by esophagectomy for esophageal cancer: An exploratory analysis of phase III trial JCOG1109.